FR2541681A1 - Process for the preparation of acycloguanosine - Google Patents
Process for the preparation of acycloguanosine Download PDFInfo
- Publication number
- FR2541681A1 FR2541681A1 FR8402884A FR8402884A FR2541681A1 FR 2541681 A1 FR2541681 A1 FR 2541681A1 FR 8402884 A FR8402884 A FR 8402884A FR 8402884 A FR8402884 A FR 8402884A FR 2541681 A1 FR2541681 A1 FR 2541681A1
- Authority
- FR
- France
- Prior art keywords
- formula
- acycloguanosine
- derivative
- acetic acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
Procédé de préparation d'acycloguanosine
La présente invention concerne un nouveau procédé pour la préparation d'acycloguanosine de formule
Process for the preparation of acycloguanosine
The present invention relates to a new process for the preparation of acycloguanosine of formula
A la différence des procédés connus jusqu' ce jour, le procédé selon l'invention consiste à transformer une guanine dont les groupes fonctionnels amine en position 2 et hydroxyle en position 6 sont protégés au moyen de réac- tifs appropriés en une acycloguanosine protégée, qui se transforme facilement en acycloguanosine.Unlike the processes known to date, the process according to the invention consists in transforming a guanine in which the functional groups amine in position 2 and hydroxyl in position 6 are protected by means of suitable reagents into a protected acycloguanosine, which easily converts to acycloguanosine.
Les avantages du procédé sont des rendements globaux plus élevés, l'usage de réactifs peu coûteux, faciles a obtenir dans le commerce et non dangereux, et enfin la possibilité de réaliser différentes opérations en deux phases distinctes ou directement en une phase unique.The advantages of the process are higher overall yields, the use of inexpensive reagents, easy to obtain commercially and not dangerous, and finally the possibility of carrying out different operations in two distinct phases or directly in a single phase.
La guanine (1), dans une solution de diméthylformamide contenant une base organique ou inorganique, est traitée par le benzaldéhyde afin d'obtenir la base de Schiff (2), et celle-ci par l'anhydride acétique ou le chlorure daacétyle afin de transformer la base de Schiff (2) en son dérivé acétylé (3). Guanine (1), in a solution of dimethylformamide containing an organic or inorganic base, is treated with benzaldehyde in order to obtain Schiff base (2), and the latter with acetic anhydride or daacetyl chloride in order to transform the Schiff base (2) into its acetylated derivative (3).
Le composé (3), en présence d'une amine tertiaire et de 1-acétoxy-2-chlorométhyloxyéthane (4), fournit le dérivé (5) qui, par hydrolyse par l'ammoniaque et l'acide acétique, se transforme en acycloguanosine.Compound (3), in the presence of a tertiary amine and 1-acetoxy-2-chloromethyloxyethane (4), provides the derivative (5) which, by hydrolysis with ammonia and acetic acid, turns into acycloguanosine .
Les transformations ci-dessus sqnt montrées par le schéma de réaction ci-après
The above transformations are shown by the following reaction scheme
Chacune des réactions décrites peut s'effectueren séparant les produits intermédiaires obtenus, ou, comme décrit plus loin dans l'exemple, le processus peut s'effectuer en une phase unique ou en plusieurs temps successifs.Each of the reactions described can be carried out by separating the intermediate products obtained, or, as described later in the example, the process can be carried out in a single phase or in several successive times.
Dans la première réaction, la guanine est dissoute dans un solvant approprié (par exemple le diméthylformamide ou des solvants similaires : si on désire conduire le processus en une phase unique, il est nécessaire d'utiliser des solvants aprotiques, mais polaires, à cause de la faible solubilité de la guanine dans les solvants non polaires), on ajoute une base (de préférence une amine tertiaire en quantité équimoléculaire), du benzaldéhyde en quantité équimoléculaire, et, si on désire opérer en une phase unique, un agent déshydratant, par exemple du sulfate de sodium anhydre ou des résines moléculaires.In the first reaction, the guanine is dissolved in an appropriate solvent (for example dimethylformamide or similar solvents: if it is desired to conduct the process in a single phase, it is necessary to use aprotic, but polar, solvents, because of the low solubility of guanine in non-polar solvents), a base (preferably a tertiary amine in equimolecular amount), benzaldehyde in equimolecular amount is added, and, if it is desired to operate in a single phase, a dehydrating agent, by example of anhydrous sodium sulfate or molecular resins.
Dans la seconde réaction, le mélange obtenu par la première réaction est directement traité par l'anhydride acétique ou le chlorure d'acétyle en quantité pouvant varier de 1 à 2 moles par mole afin d'acétyler le groupe hydroxyle.In the second reaction, the mixture obtained by the first reaction is directly treated with acetic anhydride or acetyl chloride in an amount which can vary from 1 to 2 moles per mole in order to acetylate the hydroxyl group.
La troisième réaction peut s'effectuer directement sur le mélange obtenu par la seconde réaction; à ce mélange, on ajoute une autre molécule de base (de préférence une amine tertiaire, la même que celle utilisée dans la première réac- tion) et le réactif (4) en quantité moléculaire.The third reaction can be carried out directly on the mixture obtained by the second reaction; To this mixture is added another basic molecule (preferably a tertiary amine, the same as that used in the first reaction) and the reagent (4) in molecular quantity.
La dernière réaction consiste à éliminer les groupes protecteurs par traitement à l'ammoniac , afin d'hydrolyser le groupe acétyle et, en partie, la base de Schiff; l'hydrolyse complète de cette dernière est obtenue par l'addition d'acide acétique et par un chauffage doux.The last reaction consists in removing the protective groups by treatment with ammonia, in order to hydrolyze the acetyl group and, in part, the Schiff base; the complete hydrolysis of the latter is obtained by the addition of acetic acid and by gentle heating.
Le réactif (4) se prépare facilement à partir du monoacétate d'éthylèneglycol, à l'aide du formaldéhyde et de l'acide chlorhydrique. The reagent (4) is easily prepared from ethylene glycol monoacetate, using formaldehyde and hydrochloric acid.
Un exemple de réalisation de la présente invention est décrit ci-après à titre illustratif et non limitatif.An exemplary embodiment of the present invention is described below by way of illustration and not limitation.
EXEMPLE
On dissout 15,1 g de guanine dans la quantité minimale de diméthylformamide, contenant 10,1 g de triéthylamine anhydre et 10,6 g de benzaldéhyde.EXAMPLE
15.1 g of guanine are dissolved in the minimum quantity of dimethylformamide, containing 10.1 g of anhydrous triethylamine and 10.6 g of benzaldehyde.
En chauffant doucement le mélange, on ajoute des résines moléculaires afin d'éliminer l'eau qui se forme dans la réaction et on agite jusqu'à la fin de cette réaction.By gently heating the mixture, molecular resins are added to remove the water that forms in the reaction and stirred until the reaction is complete.
On sépare les résines de la solution par décantation et on ajoute 11 g d'anhydride acétique, puis on chauffe le mélange jusqu'à réaction complète.The resins are separated from the solution by decantation and 11 g of acetic anhydride are added, then the mixture is heated until complete reaction.
Enfin, on laisse refroidir, on ajoute 15 g de triéthylamine anhydre et 16 g de 1-acétoxy-2-chlorométhyloxyéthane, et pour terminer on chauffe encore la solution sous agitation à 50-800C Jusqu'à ce que la substitution en position 9 soit terminée.Finally, it is allowed to cool, 15 g of anhydrous triethylamine and 16 g of 1-acetoxy-2-chloromethyloxyethane are added, and finally the solution is further heated with stirring at 50-800C until the substitution in position 9 is finished.
On dilue ensuite par 50 mi de méthanol saturé d'ammoniac gazeux. On transfere le mélange dans un autoclave et on chauffe à 50-800C jusqu'd hydrolyse complète.Then diluted with 50 ml of methanol saturated with gaseous ammonia. The mixture is transferred to an autoclave and heated to 50-800C until complete hydrolysis.
Enfin, on laisse refroidir, on évapore les substances volatiles sous vide, on ajoute de l'acide acétique à 95% pour obtenir une réaction nettement acide, et on agite le mélange à température ambiante jusqu 5 à hydrolyse complète de la base de Schiff.Finally, it is allowed to cool, the volatile substances are evaporated under vacuum, 95% acetic acid is added to obtain a clearly acidic reaction, and the mixture is stirred at room temperature until complete hydrolysis of the Schiff base.
A la fin de la réaction, on évapore sous vide les substances volatiles, on dilue le résidu à l'eau, on règle le pH de manière à obtenir la précipitation maximale de l'acycloguanosine; cette dernière, après filtration et lavage à l'hexane, est recristallisée jusqu'au point de fusion constant de 2560C. At the end of the reaction, the volatile substances are evaporated under vacuum, the residue is diluted with water, the pH is adjusted so as to obtain the maximum precipitation of acycloguanosine; the latter, after filtration and washing with hexane, is recrystallized to the constant melting point of 2560C.
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES520140A ES8403904A1 (en) | 1983-02-25 | 1983-02-25 | Process for the preparation of acycloguanosine |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2541681A1 true FR2541681A1 (en) | 1984-08-31 |
FR2541681B1 FR2541681B1 (en) | 1986-10-10 |
Family
ID=8485386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8402884A Expired FR2541681B1 (en) | 1983-02-25 | 1984-02-24 | PROCESS FOR THE PREPARATION OF ACYCLOGUANOSINE |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES8403904A1 (en) |
FR (1) | FR2541681B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0184473A1 (en) * | 1984-10-26 | 1986-06-11 | Merck & Co. Inc. | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives |
EP0464511A2 (en) * | 1990-06-27 | 1992-01-08 | Hoechst Aktiengesellschaft | Process for the preparation of acyclic, substituted nucleosides and its intermediates |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2047457B1 (en) * | 1992-08-03 | 1994-10-01 | Union Quimico Farma | PROCEDURE TO OBTAIN ACICLOVIR. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2282892A1 (en) * | 1974-09-02 | 1976-03-26 | Wellcome Found | PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT |
FR2342972A2 (en) * | 1976-03-01 | 1977-09-30 | Wellcome Found | PURINE DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF VIRAL INFECTIONS |
-
1983
- 1983-02-25 ES ES520140A patent/ES8403904A1/en not_active Expired
-
1984
- 1984-02-24 FR FR8402884A patent/FR2541681B1/en not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2282892A1 (en) * | 1974-09-02 | 1976-03-26 | Wellcome Found | PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT |
FR2342972A2 (en) * | 1976-03-01 | 1977-09-30 | Wellcome Found | PURINE DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF VIRAL INFECTIONS |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0184473A1 (en) * | 1984-10-26 | 1986-06-11 | Merck & Co. Inc. | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives |
EP0464511A2 (en) * | 1990-06-27 | 1992-01-08 | Hoechst Aktiengesellschaft | Process for the preparation of acyclic, substituted nucleosides and its intermediates |
EP0464511A3 (en) * | 1990-06-27 | 1992-07-15 | Hoechst Aktiengesellschaft | Process for the preparation of acyclic, substituted nucleosides and its intermediates |
US5225550A (en) * | 1990-06-27 | 1993-07-06 | Hoechst Aktiengesellschaft | Process for the preparation of substituted acyclic nucleosides, and intermediates occurring therein |
Also Published As
Publication number | Publication date |
---|---|
FR2541681B1 (en) | 1986-10-10 |
ES520140A0 (en) | 1984-04-01 |
ES8403904A1 (en) | 1984-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2541681A1 (en) | Process for the preparation of acycloguanosine | |
EP0168293B1 (en) | Process for preparing trifluoroacetic anhydride | |
JP3268825B2 (en) | Method for producing alkyl 3-chloroanthranilate | |
EP0200840B1 (en) | Process for the preparation of 6-(low)alkoxy-1-naphthoic acids, possibly halogenated at position 5, and the corresponding esters | |
CA1310327C (en) | Process for the preparation of hydroxyalkylation agents, new agents thus obtained and their use | |
IE49091B1 (en) | A novel process for the preparation of 2',6'-dialkyl-n-alkoxymethyl-2-chloro-acetanilides | |
EP0004211B1 (en) | Synthesis of nitro-2 methyl-2 propanol-1 | |
EP0185559B2 (en) | Process for the preparation of primary and/or tertiary alkyl halides | |
EP0399901A1 (en) | Process for the preparation of 1-(3-chloro-2-hydroxy-propyl)-2 methyl-5 nitro imidazol | |
EP0519984A1 (en) | Process for preparing hydroxyalkyl-1 nitro-5 imidazoles | |
BE634436A (en) | ||
JPS63154643A (en) | Production of lower carboxylic acid ester | |
EP0497065B1 (en) | Industrial process for the preparation of phosphonic derivatives of vinblastine | |
EP0888318A1 (en) | Improved method for preparing 3-(10-phenothiazyl)propanoic or 3-(10-phenoxazyl)propanoic acid derivatives | |
CA1184208A (en) | Process for preparing ethylenic haloacetals | |
EP0154045A2 (en) | Use of stilbene derivatives for the preparation of antigens, and antigens obtained | |
FR2519977A1 (en) | PROCESS FOR THE PREPARATION OF SUBSTITUTED CHLOROACETANILIDES | |
SU1097619A1 (en) | Process for preparing indol-7-carboxylic acid | |
FR2632643A1 (en) | NOVEL PROCESS FOR THE PREPARATION OF AMINO-1-METHYLPHOSPHONIC ACID N- (VINBLASTINOYL-23) DERIVATIVES | |
JP2708617B2 (en) | Method for producing 4,4-dialkyl-substituted thiazolidinethione | |
JPH08208587A (en) | Purification of n,o-dialkylhydroxamic acid and o-alkylhydroxamic acid | |
FR2578840A2 (en) | Process for the preparation of halogenated tertiary allyl esters and halogenated tertiary allyl esters thus obtained | |
FR2489824A1 (en) | PROCESS FOR THE PREPARATION OF APOVINCAMINIC ACID ESTERS AND PRODUCTS THUS OBTAINED | |
FR2568882A1 (en) | Process for the production of N-phosphonomethylglycines | |
FR2653127A1 (en) | Process for the preparation of 12-oxocholanates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |